Physician profile
Kenneth Leopold
NPI 1871561472
$1,456.84
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,175 · 2020: $282.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $230.96 | 2019-2020 | |
| Novo Nordisk INC | $225.93 | 2019 | |
| Janssen Pharmaceuticals, INC | $136.33 | 2019 | |
| Astellas Pharma US INC | $133.97 | 2019 | |
| Allergan, INC. | $112.47 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $76.57 | 2019-2020 | |
| Lilly USA, LLC | $69.14 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $57.83 | 2019 | |
| Radius Health, INC. | $53.54 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $49.38 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $48.03 | 2019-2020 | |
| Amarin Pharma, INC. | $45.74 | 2019-2020 | |
| Glaxosmithkline, LLC. | $39.55 | 2019-2020 | |
| Amgen INC. | $30.03 | 2019-2020 | |
| Acorda Therapeutics, INC | $27.42 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $20.19 | 2019 | |
| Indivior INC. | $18.31 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.25 | 2020 | |
| Pfizer INC. | $15.03 | 2020 | |
| Eisai INC. | $14.30 | 2020 | |
| Abbvie INC. | $12.72 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.22 | 2019 | |
| Novartis Pharmaceuticals Corporation | $10.93 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Leopold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.